APRE vs FITB · $10.4M cap vs P/E 17, rev $3.37B
Aprea Therapeutics Inc (APRE) versus Fifth Third Bancorp (FITB) — a side-by-side from cached financials, not a winner call.
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
APRE does not have a complete income-statement cache yet.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
APRE currently screens at market cap $10.4M. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
Not investment advice. Open the APRE and FITB stock pages for the full models.
Not investment advice.